BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11018557)

  • 1. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.
    Freytag T; Dashevsky A; Tillman L; Hardee GE; Bodmeier R
    J Control Release; 2000 Oct; 69(1):197-207. PubMed ID: 11018557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique.
    Dinarvand R; Moghadam SH; Sheikhi A; Atyabi F
    J Microencapsul; 2005 Mar; 22(2):139-51. PubMed ID: 16019900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.
    Pistel KF; Kissel T
    J Microencapsul; 2000; 17(4):467-83. PubMed ID: 10898087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
    Herrmann J; Bodmeier R
    Eur J Pharm Biopharm; 1998 Jan; 45(1):75-82. PubMed ID: 9689538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
    Cho M; Sah H
    J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment.
    Alex R; Bodmeier R
    J Microencapsul; 1990; 7(3):347-55. PubMed ID: 2384837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.
    Kim BK; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2005 Mar; 22(2):193-203. PubMed ID: 16019904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles.
    Meng FT; Ma GH; Qiu W; Su ZG
    J Control Release; 2003 Sep; 91(3):407-16. PubMed ID: 12932718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellulose acetate microspheres prepared by o/w emulsification and solvent evaporation method.
    Soppimath KS; Kulkarni AR; Aminabhavi TM; Bhaskar C
    J Microencapsul; 2001; 18(6):811-7. PubMed ID: 11695643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of pamidronate di-sodium salt.
    Weidenauer U; Bodmer D; Kissel T
    J Microencapsul; 2003; 20(4):509-24. PubMed ID: 12851051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
    Uchida T; Yoshida K; Goto S
    J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of antimicrobial ceftiofur drugs.
    Bodmeier R; Chen H; Davidson RG; Hardee GE
    Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of immunoglobulin G by solid-in-oil-in-water: effect of process parameters on microsphere properties.
    Marquette S; Peerboom C; Yates A; Denis L; Goole J; Amighi K
    Eur J Pharm Biopharm; 2014 Apr; 86(3):393-403. PubMed ID: 24184674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs.
    Bodmeier R; Wang J; Bhagwatwar H
    J Microencapsul; 1992; 9(1):99-107. PubMed ID: 1613649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods.
    Giunchedi P; Alpar HO; Conte U
    J Microencapsul; 1998; 15(2):185-95. PubMed ID: 9532524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro characteristics for insulin-loaded PLA microparticles prepared by w/o/w solvent evaporation method with electrolytes in the continuous phase.
    Yeh MK; Chen JL; Chiang CH
    J Microencapsul; 2004 Nov; 21(7):719-28. PubMed ID: 15799222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.